Relationship between Short- and Mid-Term Glucose Variability and Blood Pressure Profile Parameters: A Scoping Review.

Elena Vakali, Dimitrios Rigopoulos, Petros C Dinas, Ioannis-Alexandros Drosatos, Aikaterini G Theodosiadi, Andriani Vazeou, George Stergiou, Anastasios Kollias
Author Information
  1. Elena Vakali: Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, 11527 Athens, Greece. ORCID
  2. Dimitrios Rigopoulos: 414 Military Hospital for Special Diseases, Penteli, 15236 Athens, Greece.
  3. Petros C Dinas: FAME Laboratory, Department of Physical Education and Sports Science, University of Thessaly, 42100 Trikala, Greece. ORCID
  4. Ioannis-Alexandros Drosatos: 414 Military Hospital for Special Diseases, Penteli, 15236 Athens, Greece.
  5. Aikaterini G Theodosiadi: Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, 11527 Athens, Greece.
  6. Andriani Vazeou: Diabetes Center, A' Department of Pediatrics, P&A Kyriakou Children's Hospital, 11527 Athens, Greece.
  7. George Stergiou: Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, 11527 Athens, Greece.
  8. Anastasios Kollias: Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, 11527 Athens, Greece. ORCID

Abstract

Increased variability of glucose (GV) and blood pressure (BPV) is linked to a higher risk of macro- and microvascular complications and other hard endpoints. This scoping review aims to summarize the existing evidence regarding the association between the parameters of the blood pressure (BP) profile, especially BPV, with indices of short- and mid-term GV. . A literature search was conducted in the MEDLINE/PubMed, Cochrane, Embase, Web of Science, and Wiley Online Library databases. . The main findings of this review are as follows: (i) 13 studies were included, mainly with small sample sizes; (ii) there was a considerable degree of heterogeneity in the characteristics of the study participants (age range, individuals with normoglycemia, type 1 or 2 diabetes, normal BP, or hypertension), as well as in the methodologies (mainly in terms of the duration of the data collection period) and variability indices examined (mean amplitude of glycemic excursions and coefficient of glucose variation most frequently reported); and (iii) the results were heterogeneous regarding the association between GV and the parameters of the BP profile. . There is a significant lack of evidence on the association between GV and BPV. Future research implementing a standardized methodology should focus on the determinants, association, and clinical relevance of GV and BPV.

Keywords

References

  1. J Diabetes Complications. 2018 Oct;32(10):947-950 [PMID: 30087063]
  2. Diabetes Obes Metab. 2019 Dec;21(12):2587-2598 [PMID: 31282073]
  3. J Diabetes Res. 2020 Oct 12;2020:7489795 [PMID: 33123598]
  4. Diabetes Technol Ther. 2018 May;20(5):353-362 [PMID: 29688755]
  5. J Hypertens. 2023 Apr 1;41(4):527-544 [PMID: 36723481]
  6. J Diabetes Sci Technol. 2019 Jul;13(4):627-635 [PMID: 30694076]
  7. Cardiovasc Diabetol. 2018 Mar 7;17(1):36 [PMID: 29514695]
  8. J Hypertens. 2019 Sep;37(9):1775-1785 [PMID: 31219948]
  9. Nat Rev Cardiol. 2022 Oct;19(10):643-654 [PMID: 35440738]
  10. J Hypertens. 2014 Jun;32(6):1197-200 [PMID: 24781510]
  11. Curr Diabetes Rev. 2023 Feb 20;: [PMID: 36803747]
  12. Trends Endocrinol Metab. 2016 May;27(5):282-293 [PMID: 27079518]
  13. J Clin Endocrinol Metab. 2022 May 17;107(6):e2221-e2236 [PMID: 35094087]
  14. Diabetes Res Clin Pract. 2008 Jun;80(3):e4-7 [PMID: 18325620]
  15. Zhonghua Yi Xue Za Zhi. 2008 Nov 18;88(42):2977-81 [PMID: 19080075]
  16. Endocrinol Metab (Seoul). 2020 Jun;35(2):217-226 [PMID: 32615706]
  17. Int J Mol Sci. 2021 Aug 04;22(16): [PMID: 34445099]
  18. Diabetes Care. 2023 Feb 17;: [PMID: 36805169]
  19. Intern Med. 2021 Nov 15;60(22):3543-3549 [PMID: 34092728]
  20. N Engl J Med. 2002 Sep 12;347(11):797-805 [PMID: 12226150]
  21. J Hypertens. 2022 Aug 1;40(8):1449-1460 [PMID: 35708294]
  22. Intern Med. 2022 Feb 1;61(3):281-290 [PMID: 34544956]
  23. Nutrients. 2020 Apr 26;12(5): [PMID: 32357570]
  24. Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57 [PMID: 36493795]
  25. Pediatr Nephrol. 2021 Feb;36(2):379-386 [PMID: 32844291]
  26. JAMA. 2017 Jan 24;317(4):371-378 [PMID: 28118453]
  27. J Hypertens. 2016 Sep;34(9):1665-77 [PMID: 27214089]
  28. Diabetes Care. 2022 Jan 1;45(Suppl 1):S4-S7 [PMID: 34964881]
  29. BMJ. 2016 Aug 09;354:i4098 [PMID: 27511067]
  30. Cardiovasc Diabetol. 2020 Jul 4;19(1):102 [PMID: 32622354]
  31. Diabetologia. 2011 Jan;54(1):69-72 [PMID: 20886203]
  32. Circulation. 2020 Nov 10;142(19):1810-1820 [PMID: 33131317]
  33. Diabetol Metab Syndr. 2019 Apr 11;11:29 [PMID: 31044019]
  34. Blood Press Monit. 2021 Apr 1;26(2):102-107 [PMID: 33074929]
  35. Ont Health Technol Assess Ser. 2011;11(4):1-29 [PMID: 23074416]

Word Cloud

Created with Highcharts 10.0.0glucoseGVvariabilitybloodpressureBPVassociationBPreviewevidenceregardingparametersprofileindicesmainlymonitoringIncreasedlinkedhigherriskmacro-microvascularcomplicationshardendpointsscopingaimssummarizeexistingespeciallyshort-mid-termliteraturesearchconductedMEDLINE/PubMedCochraneEmbaseWebScienceWileyOnlineLibrarydatabasesmainfindingsfollows:13studiesincludedsmallsamplesizesiiconsiderabledegreeheterogeneitycharacteristicsstudyparticipantsagerangeindividualsnormoglycemiatype12diabetesnormalhypertensionwellmethodologiestermsdurationdatacollectionperiodexaminedmeanamplitudeglycemicexcursionscoefficientvariationfrequentlyreportediiiresultsheterogeneoussignificantlackFutureresearchimplementingstandardizedmethodologyfocusdeterminantsclinicalrelevanceRelationshipShort-Mid-TermGlucoseVariabilityBloodPressureProfileParameters:ScopingReviewambulatorycontinuousfluctuations

Similar Articles

Cited By